ArticleBMC cardiovascular disorders2025
The global burden of atrial fibrillation and atrial flutter in older adults (≥ 65 years): trends, disparities, and drivers (1990-2021).
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe global burden of atrial fibrillation (AF) and atrial flutter (AFL), major contributors to stroke and heart failure, has substantially increased since 1990 due to aging populations and improved chronic disease survival. This study analyzed global, regional, and national trends in AF/AFL prevalence, incidence, mortality, and disability-adjusted life years (DALYs) among those aged ≥ 65 years (1990-2021), stratified by age, sex, and socioeconomic development index (SDI).
methodsThe Global Burden of Disease (GBD) 2021 dataset provided data on AF/AFL. The analysis included age standardization, average annual percentage change (AAPC) calculations, frontier analysis, and decomposition analysis to quantify the contributions of demographic and epidemiological changes.
resultsGlobal AF/AFL cases in those aged ≥ 65 years increased significantly (1990-2021), with a 203.91% increase in deaths. However, age-standardized rates varied; high-income North America showed the highest prevalence rate in 2021 at 11,815.10 per 100,000. Decomposition analysis showed that the increase was attributable to population aging and growth. Frontier analysis revealed countries with disproportionately high DALYs relative to their SDI.
conclusionsThe escalating global burden of AF/AFL in older adults demands targeted interventions and resource allocation to address regional disparities. While demographic changes are primary drivers, further research is crucial to understand the contribution of epidemiological factors and develop effective prevention and management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.